Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 4,500 shares at $1.85 ($8K) on 2022-07-22, disclosed to the SEC on 2022-07-25.
Open-market purchase of $8k TCON by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| TCON | BUY | 2023-01-19 | $11K | — | Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |